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A 62-year-old  man  with  a  history  of  symptomatic  resistant  paroxysmal  atrial  ﬁbrillation  (AF)
underwent  percutaneous  pulmonary  vein  (PV)  isolation  with  a  28  mm  diameter  cryoballoon
catheter  (Arctic  Front®;  Medtronic  CryoCath  LP,  Pointe-Claire,  QC,  Canada).  A  20  mm  cir-
cular  loop  mapping  catheter  with  eight  evenly  spaced  electrodes  (Achieve®;  Medtronic,
Minneapolis,  MN,  USA)  was  used.  This  wire  is  especially  designed  to  combine  appropri-
ate  positioning  of  the  cryoballoon  at  the  PV  antrum  and  visualization  of  PV  potentials
throughout  cryoablation  (Fig.  1A).
The  patient  was  in  AF  at  the  beginning  of  the  procedure.  Cryoenergy  was  applied  twice,
successively,  in  the  right  inferior  PV,  right  superior  PV,  left  superior  PV  and  left  inferior  PV
(LIPV).  At  the  start  of  the  second  cryoenergy  application  at  the  LIPV  antrum,  potentials
were  clearly  visible  on  the  Achieve  catheter.  After  151  s,  we  observed  the  occurrence  of
an  atriovenous  block  and  conversion  to  sinus  rhythm.  Focal  activity  coming  from  the  PV
continued  but  was  conﬁned  to  the  vein  (Fig.  2A).  The  venous  activity  was  abolished  30  s
later  (Fig.  2B).  The  PV  tachycardia  cycle  length  increased  progressively  prior  to  break.  The
whole  application  lasted  300  s and  a  temperature  of  —57 ◦C  was  reached  (Fig.  1B).
As  in  conventional  radiofrequency  catheter  ablation,  monitoring  of  PV  activity  during
balloon  ablation  is  possible.  This  may  allow  diagnosis  of  the  culprit  pulmonary  vein  in  the
triggering  and/or  maintenance  of  AF;  it  may  also  show  the  effect  of  cryoablation.  In  this
case,  we  had  the  opportunity  to  monitor  two  effects  of  the  cryoballoon:  constitution  of
atriovenous  block  then  termination  of  PV  focal  activity.
Abbreviations: AF, atrial ﬁbrillation; LIPV, left inferior pulmonary vein; PV, pulmonary vein.
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Figure 1. A. Fluoroscopic image (front view) showing complete occlusion of the left inferior pulmonary vein (LIPV) using a cryoballoon and
a mapping catheter advanced into the pulmonary vein. A quadripolar catheter is positioned in the superior vena cava (SVC) and a decapolar
catheter is positioned in the coronary sinus (CS). An oesophageal temperature probe is also visible close to the balloon. B. Temperature
curve during application of cryotherapy.
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Cryoenergy  offers  some  advantages  over  radiofrequency
nergy.  The  stability  of  the  catheter  is  enhanced  by  an  adhe-
ive  effect  during  icing.  There  is  less  endothelial  disruption,
ower  thrombotic  risk  and  less  tissue  contraction  during
ealing.  These  effects  are  thought  to  reduce  oesophageal
isk  and  pulmonary  vein  stenosis.  The  main  limitation  is  the
alloon  size,  which  does  not  always  ﬁt  the  four  pulmonary
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eins  exactly.  There  is  also  a  risk  of  right  phrenic  nerve
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